Pancreatic Cancer Research

ResearcherInsermNo recent work listed

Wilhem Leconet

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5085025850. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 2 papers

Papers 2

  1. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Co-author DOI 10.1038/onc.2013.487↗
  2. HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models. Co-author DOI 10.18632/oncotarget.2231↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gaëlle Thomas · 2 shared papers, 2014 · strength 0.07
  2. Christel Larbouret · 2 shared papers, 2014 · strength 0.07
  3. André Pèlegrin · 2 shared papers, 2014 · strength 0.07
  4. Thierry Chardès · 2 shared papers, 2014 · strength 0.07
  5. Bruno Robert · 2 shared papers, 2014 · strength 0.07
  6. Pierre‐Emmanuel Colombo · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.